MedTrace Logo

Monitoring the Early Follicular Phase With Androstenedione in Low-dose Step-up Ovulation Induction in High Responders

NCT02329483 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-04-07

No results posted yet for this study

Summary

This study aims to predefine the threshold FSH doses during the early follicular phases in low- dose step-up ovulation induction cycles used to treat anticipated high responders by monitoring total testosterone and androstenedione blood levels. The blood levels of total testosterone and androstenedione levels will be measured in patients at the starting day and at every control day when vaginal sonographic folliculometries and blood estradiol measurements are made. Hence, we are aiming to define an early monitoring parameter by which we will be able to define a follicular response to treatment before estradiol rise or apparently selected follicular growth.

Conditions

Sponsors & Collaborators

  • Bagcilar Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Eser S Ozyurek, MD · Bagcilar Training and Research Hospital

  • Erdal Kaya, Prof Dr · Bagcilar Training and Research Hospital

  • Mustafa U Karacaoglu, MD · Bagcilar Training and Research Hospital

  • Evrim E Kovalak, MD · Bagcilar Training and Research Hospital

  • Erdinc Ergul, MD · Bagcilar Training and Research Hospital

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2015-05-31
Completion
2015-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02329483 on ClinicalTrials.gov